Article in G3 (Bethesda, Md.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 2 institutions in 2 countries.
Diana DalfóSkirball Institute of Biomolecular Medicine, Departments of Cell Biology and Pathology, NYU Grossman School of Medicine.
Yanhui DingSchool of Medicine, Tongji University.
Qifei LiangSchool of Medicine, Tongji University.
Alex FongSkirball Institute of Biomolecular Medicine, Departments of Cell Biology and Pathology, NYU Grossman School of Medicine.
Patricia Giselle CiprianiCenter for Genomics and Systems Biology, Department of Biology, New York University and Center for Genomics and Systems Biology, New York University Abu Dhabi.
Fabio PianoCenter for Genomics and Systems Biology, Department of Biology, New York University and Center for Genomics and Systems Biology, New York University Abu Dhabi.
Jialin C ZhengSchool of Medicine, Tongji University.
Zhao QinSchool of Medicine, Tongji University jane.hubbard@med.nyu.edu zqin.med@tongji.edu.cn.ORCID 0000-0003-1709-0818
E Jane Albert HubbardSkirball Institute of Biomolecular Medicine, Departments of Cell Biology and Pathology, NYU Grossman School of Medicine jane.hubbard@med.nyu.edu zqin.med@tongji.edu.cn.ORCID 0000-0001-5893-7232
Tongji University · CNNew York University · US
Funding
Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
CONTROL ONSET OF MEIOSIS IN C. ELEGANSR01GM061706 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUBBARD, E. JANE ALBERT · 2000 to 2018
$5.4M
A Systematic RNAi-based Map of C. elegans EmbryogenesisR01HD046236 · NICHD · NEW YORK UNIVERSITY · PI GUNSALUS, KRISTIN C, PIANO, FABIO · 2004 to 2013
$4.5M
" TGF-beta and sensory regulation of germline development in C. elegans".R01GM102254 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUBBARD, E. JANE ALBERT · 2012 to 2015
$1.3M
Sensory and metabolic regulation of stem cell niche functionR01GM130152 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HUBBARD, E. JANE ALBERT · 2019 to 2019
$378k
Automated, High Content Imaging PlatformS10OD021727 · OD · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI YUN, CHI · 2018 to 2018
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Genome-Wide RNAi Screen for Enhancers of a Germline Tumor Phenotype Caused by Elevated GLP-1/Notch Signaling in · full record | OpenQuestion